Mobix Labs appoints Philip Sansone as interim CEO while CEO Battaglia on sick leave

MOBIX LABS, INC

Philip Sansone appointed Interim CEO effective April 10, 2025, replacing CEO Fabian Battaglia who is on sick leave.
Sansone previously served as VP of Worldwide Sales at Mobix Labs from September 2021.
Prior to Mobix, Sansone was VP of Global Distribution at MaxLinear from April 2019 to September 2021.
Sansone will serve until Battaglia returns; no other arrangements or family relationships disclosed.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Philip Sansone

Interim Chief Executive Officer

MOBX · MOBIX LABS, INC

Effective: 2025-04-10
Filed: April 16, 2025, 7:59 PM ET

On April 10, 2025, the Board of Directors (the “Board”) of Mobix Labs, Inc. (the “Company”) appointed Philip Sansone as Interim Chief Executive Officer of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Philip Sansone was appointed as Interim Chief Executive Officer at MOBIX LABS, INC.

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

On April 10, 2025, the Board of Directors (the “Board”) of Mobix Labs, Inc. (the “Company”) appointed Philip Sansone as Interim Chief Executive Officer of the Company, effective immediately.

View on SEC.gov

MOBIX LABS, INC filing history →

Source: SEC EDGAR

accession 0001641172-25-005065

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.